
---
title: '海正药业：泊沙康唑原料药获得化学原料药上市申请批准通知书'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=395'
author: 证券时报网
comments: false
date: Mon, 29 Aug 2022 17:06:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=395'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600267" style="color: #2f67d1;text-decoration: none;" code="600267" target="_blank">海正药业</a>(600267)8月29日晚间公告，近日，公司收到国家药监局核准签发的泊沙康唑原料药的《化学原料药上市申请批准通知书》。</p>

                  
</div>
            